Sorrento Therapeutics Inc
F:8STN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Sorrento Therapeutics Inc
F:8STN
|
US |
|
P
|
POPER Co Ltd
TSE:5134
|
JP |
|
Nihon Enterprise Co Ltd
TSE:4829
|
JP |
|
WinVest Acquisition Corp
OTC:WINV
|
US |
|
T
|
Tartisan Nickel Corp
F:8TA
|
CA |
|
Fandifi Technology Corp
OTC:FDMSF
|
CA |
|
A
|
Atturra Ltd
ASX:ATA
|
AU |
|
L
|
Landmark Property Development Co Ltd
BSE:533012
|
IN |
|
A
|
Adventus Mining Corp
F:AZC
|
CA |
|
J
|
James Fisher and Sons PLC
SWB:6FJ
|
UK |
|
C
|
CTS Co Ltd
TSE:4345
|
JP |
|
B
|
bBreak Systems Co Ltd
TSE:3986
|
JP |
|
B
|
Bonso Electronics International Inc
OTC:BNSOF
|
HK |
|
C
|
Cloudberry Clean Energy ASA
OSE:CLOUD
|
NO |
Bankruptcy Probability
Sorrento Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Sorrento Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Sorrento Therapeutics Inc
OTC:SRNE
|
435k USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
470B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
239.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
183.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
139.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
86.9B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
54.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
80.3B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Sorrento Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Sorrento Therapeutics Inc has total debt of 21.7m USD. This includes both short-term (0 USD) and long-term (21.7m USD) debt.
You can find a full breakdown on its Balance Sheet.
